Analysts Are Bullish on These Healthcare Stocks: Ionis Pharmaceuticals (IONS), Celldex (CLDX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ionis Pharmaceuticals (IONS – Research Report), Celldex (CLDX – Research Report) and Pfizer (PFE – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ionis Pharmaceuticals (IONS)
William Blair analyst Myles Minter maintained a Buy rating on Ionis Pharmaceuticals today. The company’s shares closed last Wednesday at $81.73.
According to TipRanks.com, Minter is a 5-star analyst with an average return of
Currently, the analyst consensus on Ionis Pharmaceuticals is a Strong Buy with an average price target of $97.22.
See the top stocks recommended by analysts >>
Celldex (CLDX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Celldex today and set a price target of $42.00. The company’s shares closed last Wednesday at $29.17.
According to TipRanks.com, Pantginis is a 5-star analyst with an average return of
Celldex has an analyst consensus of Moderate Buy, with a price target consensus of $44.00.
Pfizer (PFE)
In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer. The company’s shares closed last Wednesday at $26.75.
According to TipRanks.com, Raffat is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Pfizer with a $28.66 average price target.
